| Association of treatment with nirmatrelvir and the risk of post–COVID-19 condition Y Xie, T Choi, Z Al-Aly JAMA Internal Medicine 183 (6), 554-564, 2023 | 123 | 2023 |
| Nirmatrelvir and the risk of post-acute sequelae of COVID-19 Y Xie, T Choi, Z Al-Aly MedRxiv, 2022.11. 03.22281783, 2022 | 49 | 2022 |
| Risk of death in patients hospitalized for COVID-19 vs seasonal influenza in fall-winter 2022-2023 Y Xie, T Choi, Z Al-Aly Jama 329 (19), 1697-1699, 2023 | 48 | 2023 |
| Molnupiravir and risk of post-acute sequelae of covid-19: cohort study Y Xie, T Choi, Z Al-Aly bmj 381, 2023 | 36 | 2023 |
| Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study Y Xie, T Choi, Z Al-Aly The Lancet Infectious Diseases 24 (3), 239-255, 2024 | 12 | 2024 |
| Data analysis using representation theory and clustering algorithms S Alkhushayni, T Choi, D Alzaleq WSEAS Trans. Comput 19, 310-320, 2020 | 9 | 2020 |
| Nirmatrelvir and the Risk of Post-Acute Sequelae of COVID-19 (preprint) Y Xie, T Choi, Z Al-Aly | | 2022 |
| Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024 Y Xie, T Choi, Z Al-Aly JAMA, 0 | | |
